leadf
logo-loader
viewZoetic International PLC

Zoetic Interntnl PLC - Exercise of Share Options

RNS Number : 5105D
Zoetic International PLC
28 October 2020
 

Prior to publication, the information contained within this announcement was deemed by the Company to constitute inside information for the purposes of Article 7 under the Market Abuse Regulation (EU) No. 596/2014 ("MAR"). With the publication of this announcement, this information is now considered to be in the public domain.

 

28 October 2020

 

Zoetic International plc

 

("Zoetic" or the "Company" or the "Group")

 

Exercise of Share Options

 

Zoetic International plc (LSE: ZOE), the London-listed vertically integrated CBD company, is pleased to announce that it has today issued 1,000,000 ordinary shares of 1 pence each ("Ordinary Shares") following the exercise of options under the Company's share option scheme (as announced on 8 October 2019), at an exercise price of 10 pence per Ordinary Share (the "Option Shares").

 

Application will be made to the London Stock Exchange for the Option Shares to be admitted to trading on the Main Market of the London Stock Exchange and the Standard Segment of the FCA Official List ("Admission"). It is expected that Admission will become effective and that dealings in the Option Shares on the Main Market of the London Stock Exchange will commence on or around 3 November 2020.

 

On Admission, the Company will have 195,570,034 Ordinary Shares in issue, each with one voting right.  There are no shares held in treasury. Therefore, the Company's total number of Ordinary Shares and voting rights will be 195,570,034 and this figure may be used by shareholders from Admission as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

**ENDS**

 

Enquiries

 

Zoetic International plc                                                                                         c/o IFC Advisory

Trevor Taylor, Co-CEO

 

Allenby Capital Limited (Financial Adviser and Broker)                                +44 (0) 20 3328 5656

Nick Harriss (Corporate Finance)

Nick Naylor (Corporate Finance)

Guy McDougall (Equity Sales)

 

IFC Advisory Ltd (Financial PR and IR)                                                               +44 (0) 20 3934 6630

Tim Metcalfe

Graham Herring

Florence Chandler

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEXVLFLBBLFFBZ

Quick facts: Zoetic International PLC

Price: -

Market: LSE
Market Cap: -
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Zoetic forms second international distribution contract to reach over 15...

Zoetic International PLC (LON:ZOE) Co-CEOs Antonio Russo and Trevor Taylor tell Proactive the London-listed vertically integrated CBD company has signed its second international distribution contract, as well as noting continued progress with its core CBD business. Russo and Taylor say the...

on 09/10/2020

3 min read